文献
J-GLOBAL ID:202102232071163667
整理番号:21A0021940
重症アレルギー性喘息の小児,青年および成人におけるオマリズマブの有効性: 重症喘息の評価に対する現行ガイドラインを用いた新たな試験に対する系統的レビュー,メタ分析および新たな試み【JST・京大機械翻訳】
Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma
著者 (12件):
Henriksen Daniel P.
(Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark)
,
Henriksen Daniel P.
(Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark)
,
Bodtger Uffe
(Department of Respiratory Medicine, Naestved Hospital, Naestved, Denmark)
,
Bodtger Uffe
(Department of Medicine, Zealand University Hospital, Roskilde, Denmark)
,
Sidenius Kirsten
(Allergi og Lungeklinikken Helsingor, Helsingor, Denmark)
,
Maltbaek Niels
(Department of Medicine, Zealand University Hospital, Roskilde, Denmark)
,
Pedersen Lars
(Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen, Denmark)
,
Madsen Hanne
(Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark)
,
Andersson Ehm A.
(The Danish Medicines Council Secretariat, Copenhagen, Denmark)
,
Norgaard Ole
(The Danish Medicines Council Secretariat, Copenhagen, Denmark)
,
Madsen Louise K.
(The Danish Medicines Council Secretariat, Copenhagen, Denmark)
,
Chawes Bo L.
(COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte University Hospital, University of Copenhagen, Copenhagen, Denmark)
資料名:
Allergy, Asthma & Clinical Immunology (Web)
(Allergy, Asthma & Clinical Immunology (Web))
巻:
16
号:
1
ページ:
1-12
発行年:
2020年
JST資料番号:
U7406A
ISSN:
1710-1492
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
イギリス (GBR)
言語:
英語 (EN)